CL
BMY

Christopher S. Boerner

Known title: DirectorCIK: 0001543747

Christopher S. Boerner's purchase track record

Christopher S. Boerner has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.

PurchaseStockAmount3 months6 months
2/20/2025BMY$110K-14.8%-11.1%
11/28/2023BMY$250K+4.5%-15.3%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Colgate-Palmolive dividend focus ahead of Q3 earnings call. Recent coverage lists Colgate‑Palmolive as a dividend champion and a contender for income‑focused investors. The company will host its 2026 third‑quarter earnings webcast on October 30, where results and guidance are expected. Investors noting the upcoming November 13 dividend should be aware of the October 20 record date to qualify for the payment. The stock continues to trade with a dividend yield of about 2.5%.

this person other insiders at CL

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Bristol Myers Squibb sees mixed trial results and dividend focus. Recent articles note BMY's 4.2% dividend yield and the trade‑off investors face between income and growth. Analysts also point to momentum in the stock rally but question whether new drugs can sustain further upside, especially after mixed Phase 3 results for its pulmonary fibrosis treatment. A shift in the company's portfolio toward newer products is also highlighted, adding context to the current market view.

this person other insiders at BMY

Transaction History

CL▲ Buy$0
BMY▼ Sell$0
BMY▼ Sell$632K
BMY▲ Buy$0
BMY▼ Sell$0
BMY▼ Sell$279K
BMY▲ Buy$0
BMY▼ Sell$0
BMY▼ Sell$181K
BMY▲ Buy$0
BMY▼ Sell$0
BMY▼ Sell$185K
BMY▲ Buy$0
BMY▲ Buy$0
BMY▼ Sell$57K
BMY▼ Sell$0
BMY▼ Sell$0
BMY▼ Sell$0
BMY▼ Sell$0
BMY▼ Sell$0
BMY▼ Sell$210K
BMY▲ Buy$0
BMY▼ Sell$0
BMY▼ Sell$176K
BMY▲ Buy$0
BMY▼ Sell$0
BMY▼ Sell$180K
BMY▲ Buy$0
BMY▼ Sell$0
BMY▼ Sell$809K
BMY▲ Buy$0
BMY▼ Sell$0
BMY▲ Buy$110K
BMY▲ Buy$0
BMY▼ Sell$0
BMY▼ Sell$81K
BMY▲ Buy$0
BMY▼ Sell$0
BMY▼ Sell$133K
BMY▲ Buy$0
BMY▼ Sell$0
BMY▼ Sell$159K
BMY▲ Buy$0
BMY▼ Sell$752K
BMY▼ Sell$0
BMY▲ Buy$100K
BMY▲ Buy$0
BMY▼ Sell$68K
BMY▲ Buy$150K
BMY▼ Sell$273K
BMY▲ Buy$0
BMY▼ Sell$230K
BMY▲ Buy$0
BMY▼ Sell$1.3M
BMY▼ Sell$0
BMY▼ Sell$0
BMY▼ Sell$0
BMY▲ Buy$0
BMY▼ Sell$0
BMY▼ Sell$244K
BMY▲ Buy$0
BMY▼ Sell$229K
BMY▲ Buy$0
BMY▼ Sell$0
BMY▼ Sell$109K
BMY▲ Buy$0
BMY▼ Sell$2.0M
BMY▲ Buy$0
BMY▼ Sell$0
BMY▲ Buy$0
BMY▼ Sell$0
BMY▼ Sell$227K
BMY▲ Buy$0
BMY▲ Buy$0
BMY▼ Sell$272K
BMY▲ Buy$0
BMY▲ Buy$0
BMY▼ Sell$1.6M
BMY▼ Sell$63K
BMY▲ Buy$0
BMY▼ Sell$0
BMY▼ Sell$243K
BMY▲ Buy$0
BMY▼ Sell$75K

We use analytics to understand how market-wall is used. No personal data is sold.